University of Victoria, Victoria, British Columbia, Canada.
BC Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada.
J Appl Clin Med Phys. 2024 Sep;25(9):e14459. doi: 10.1002/acm2.14459. Epub 2024 Jul 25.
SRS MapCHECK (SMC) is a commercially available patient-specific quality assurance (PSQA) tool for stereotactic radiosurgery (SRS) applications. This study investigates the effects of degree of modulation, location off-axis, and low dose threshold (LDT) selection on gamma pass rates (GPRs) between SMC and treatment planning system, Analytical Anisotropic Algorithm (AAA), or Vancouver Island Monte Carlo (VMC++ algorithm) system calculated dose distributions.
Volumetric-modulated arc therapy (VMAT) plans with modulation factors (MFs) ranging from 2.7 to 10.2 MU/cGy were delivered to SMC at isocenter and 6 cm off-axis. SMC measured dose distributions were compared against AAA and VMC++ via gamma analysis (3%/1 mm) with LDT of 10% to 80% using SNC Patient software.
Comparing on-axis SMC dose against AAA and VMC++ with LDT of 10%, all AAA-calculated plans met the acceptance criteria of GPR ≥ 90%, and only one VMC++ calculated plan was marginally outside the acceptance criteria with pass rate of 89.1%. Using LDT of 80% revealed decreasing GPR with increasing MF. For AAA, GPRs reduced from 100% at MF of 2.7 MU/cGy to 57% at MF of 10.2 MU/cGy, and for VMC++ calculated plans, the GPRs reduced from 89% to 60% in the same MF range. Comparison of SMC dose off-axis against AAA and VMC++ showed more pronounced reduction of GPR with increasing MF. For LDT of 10%, AAA GPRs reduced from 100% to 83% in the MF range of 2.7 to 9.8 MU/cGy, and VMC++ GPR reduced from 100% to 91% in the same range. With 80% LDT, GPRs dropped from 100% to 42% for both algorithms.
MF, dose calculation algorithm, and LDT selections are vital in VMAT-based SRT PSQA. LDT of 80% enhances sensitivity of gamma analysis for detecting dose differences compared to 10% LDT. To achieve better agreement between calculated and SMC dose, it is recommended to limit the MF to 4.6 MU/cGy on-axis and 3.6 MU/cGy off-axis.
SRS MapCHECK(SMC)是一种商用的立体定向放射外科(SRS)应用患者特定质量保证(PSQA)工具。本研究旨在探讨调制程度、离轴位置和低剂量阈值(LDT)选择对 SMC 与治疗计划系统(AAA 分析各向异性算法或 VMC++算法)计算剂量分布之间伽马通过率(GPR)的影响。
在等中心和离轴 6cm 处将调制因子(MF)范围为 2.7 至 10.2MU/cGy 的容积调制弧形治疗(VMAT)计划传送给 SMC。使用 SNC Patient 软件,SMC 测量的剂量分布与 AAA 和 VMC++进行伽马分析(3%/1mm)比较,LDT 为 10%至 80%。
比较 LDT 为 10%时轴上 SMC 剂量与 AAA 和 VMC++,所有 AAA 计算的计划均符合 GPR≥90%的接受标准,只有一个 VMC++计算的计划略低于接受标准,通过率为 89.1%。使用 LDT 为 80%时,随着 MF 的增加,GPR 逐渐降低。对于 AAA,GPR 从 MF 为 2.7MU/cGy 时的 100%降至 MF 为 10.2MU/cGy 时的 57%,而对于 VMC++计算的计划,GPR 从同一 MF 范围的 89%降至 60%。SMC 离轴剂量与 AAA 和 VMC++的比较表明,随着 MF 的增加,GPR 的降低更为明显。LDT 为 10%时,AAA 的 GPR 从 MF 为 2.7 至 9.8MU/cGy 的范围内从 100%降至 83%,而 VMC++的 GPR 从同一范围内的 100%降至 91%。LDT 为 80%时,两种算法的 GPR 从 100%降至 42%。
MF、剂量计算算法和 LDT 的选择在基于 VMAT 的 SRT PSQA 中至关重要。与 10%LDT 相比,LDT 为 80%可提高伽马分析检测剂量差异的灵敏度。为了使计算剂量与 SMC 剂量更好地吻合,建议将轴上的 MF 限制在 4.6MU/cGy,离轴的 MF 限制在 3.6MU/cGy。